Free Access
Issue
Biologie Aujourd'hui
Volume 205, Number 1, 2011
Page(s) 29 - 31
Section Physiopathologie et génétique de l’épilepsie : données récentes
DOI https://doi.org/10.1051/jbio/2011003
Published online 19 avril 2011
  • Gorter J.A., van Vliet E.A., Aronica E., Breit T., Rauwerda H., Lopes da Silva F., Wadman W.J., Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. J Neurosci, 2006, 26, 11083–11110. [CrossRef] [PubMed] [Google Scholar]
  • Löscher W., Schmidt D., New horizons in the development of antiepileptic drugs: innovative strategies. Epilepsy Res, 2006, 69, 183–2721. [CrossRef] [PubMed] [Google Scholar]
  • Scheffer I.E., Berkovic S.F., The genetics of human epilepsy. TIPS, 2003, 24, 428–433. [Google Scholar]
  • Vezzani A.M., Granata T., Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia, 2005, 46, 1724–1743. [CrossRef] [PubMed] [Google Scholar]
  • Wickenden A.D., Potassium channels as anti-epileptic drug targets. Neuropharmacol, 2002, 43, 1055–1060. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.